A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.
Crimean-Congo Haemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15-70% of reported cases are fatal. There is no approved vaccine available, and preclinical protection in vivo by an experimental vaccine has...
Guardado en:
Autores principales: | Karen R Buttigieg, Stuart D Dowall, Stephen Findlay-Wilson, Aleksandra Miloszewska, Emma Rayner, Roger Hewson, Miles W Carroll |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aba057ddb4854297b22a7735d65ed399 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Presence of antibodies to Crimean Congo haemorrhagic fever virus in sheep in Tunisia, North Africa
por: Médiha Khamassi Khbou, et al.
Publicado: (2021) -
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
por: Sergio E. Rodriguez, et al.
Publicado: (2019) -
Transfusion Strategy in Crimean-Congo Hemorrhagic Fever Treatment
por: Ali Jabbari, et al.
Publicado: (2021) -
CRIMEAN-CONGO HEMORRHAGIC FEVER (CCHF); A CASE REPORT
por: Syeda Fatimah Zareen, et al.
Publicado: (2020) -
Aptamer based diagnosis of crimean-congo hemorrhagic fever from clinical specimens
por: Tahmineh Jalali, et al.
Publicado: (2021)